Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Marie Berthelot

Showing results (1-10 of 186) with videos related to

Pageof 19
Sort By:
La Revue Du Praticien|June 22, 2005
[Algodystrophy]Jean-Marie Berthelot
La Revue Du Praticien|October 19, 2019
[Placebo effect in osteoarthritis]Jean-Marie Berthelot
Joint Bone Spine|December 19, 2015
Is electromagnetic hypersensitivity entirely ascribable to nocebo effects?Jean-Marie Berthelot
Joint Bone Spine|November 8, 2011
Comments about the article by Mouterde et al. entitled "Indications of glucocorticoids in early arthritis and rheumatoid arthritis: Recommendations for clinical practice based on data from the literature and expert opinions". Joint Bone Spine 2010;77:597-603. Low-dose prednisone and biologics: allies rather than competitors?Jean-Marie Berthelot
Joint Bone Spine|September 21, 2010
The placebo effect in rheumatology: new dataJean-Marie Berthelot
Joint Bone Spine|July 14, 2006
Current management of reflex sympathetic dystrophy syndrome (complex regional pain syndrome type I)Jean-Marie Berthelot
Joint Bone Spine|April 7, 2012
Efficacy of low-dose etanercept (25 mg/week): how much do we know?Jean-Marie Berthelot
Joint Bone Spine|May 11, 2020
Over-treatment in rheumatologyJean-Marie Berthelot
Joint Bone Spine|August 4, 2004
Is dosage reduction appropriate in patients who respond well to anti-TNF-alpha agents?Jean-Marie Berthelot, Stéphane Varin
Joint Bone Spine|January 25, 2019
Translocation of dead or alive bacteria from mucosa to joints and epiphyseal bone-marrow: facts and hypothesesJean-Marie Berthelot, Daniel Wendling
Pageof 19

Showing results (1-10 of 186) with videos related to

Sort By:
Pageof 19
La Revue Du Praticien|June 22, 2005
[Algodystrophy]Jean-Marie Berthelot
La Revue Du Praticien|October 19, 2019
[Placebo effect in osteoarthritis]Jean-Marie Berthelot
Joint Bone Spine|December 19, 2015
Is electromagnetic hypersensitivity entirely ascribable to nocebo effects?Jean-Marie Berthelot
Joint Bone Spine|November 8, 2011
Comments about the article by Mouterde et al. entitled "Indications of glucocorticoids in early arthritis and rheumatoid arthritis: Recommendations for clinical practice based on data from the literature and expert opinions". Joint Bone Spine 2010;77:597-603. Low-dose prednisone and biologics: allies rather than competitors?Jean-Marie Berthelot
Joint Bone Spine|September 21, 2010
The placebo effect in rheumatology: new dataJean-Marie Berthelot
Joint Bone Spine|July 14, 2006
Current management of reflex sympathetic dystrophy syndrome (complex regional pain syndrome type I)Jean-Marie Berthelot
Joint Bone Spine|April 7, 2012
Efficacy of low-dose etanercept (25 mg/week): how much do we know?Jean-Marie Berthelot
Joint Bone Spine|May 11, 2020
Over-treatment in rheumatologyJean-Marie Berthelot
Joint Bone Spine|August 4, 2004
Is dosage reduction appropriate in patients who respond well to anti-TNF-alpha agents?Jean-Marie Berthelot, Stéphane Varin
Joint Bone Spine|January 25, 2019
Translocation of dead or alive bacteria from mucosa to joints and epiphyseal bone-marrow: facts and hypothesesJean-Marie Berthelot, Daniel Wendling
Pageof 19